Patents by Inventor Everardus Orlemans

Everardus Orlemans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for delivering a pharmaceutical composition to patient in need thereof
    Patent number: 9801824
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 12, 2016
    Date of Patent: October 31, 2017
    Assignees: Pozen Inc., Horizon Pharma USA, Inc.
    Inventors: Brian Ault, Everardus Orlemans, John R. Plachetka, Mark Sostek
  • METHOD FOR DELIVERING A PHARMACEUTICAL COMPOSITION TO PATIENT IN NEED THEREOF
    Publication number: 20170071861
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 12, 2016
    Publication date: March 16, 2017
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Everardus ORLEMANS, John R. PLACHETKA, Mark SOSTEK
  • Method for delivering a pharmaceutical composition to patient in need thereof
    Patent number: 9393208
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: July 19, 2016
    Assignees: Pozen Inc., Horizon Pharma USA, Inc.
    Inventors: Brian Ault, Everardus Orlemans, John R. Plachetka, Mark Sostek
  • METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER
    Publication number: 20160166558
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: February 23, 2016
    Publication date: June 16, 2016
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Clara HWANG, Everardus Orlemans, John R. PLACHETKA, Mark SOSTEK
  • METHOD FOR DELIVERING A PHARMACEUTICAL COMPOSITION TO PATIENT IN NEED THEREOF
    Publication number: 20160106678
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 28, 2015
    Publication date: April 21, 2016
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Everardus ORLEMANS, John R. PLACHETKA, Mark SOSTEK
  • Method for delivering a pharmaceutical composition to patient in need thereof
    Patent number: 9220698
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: December 29, 2015
    Assignees: Pozen Inc., Horizon Pharma USA, Inc.
    Inventors: Brian Ault, Mark Sostek, Everardus Orlemans, John R. Plachetka
  • METHOD FOR TREATING A PATIENT AT RISK FOR DEVELOPING AN NSAID-ASSOCIATED ULCER
    Publication number: 20150202193
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: January 9, 2015
    Publication date: July 23, 2015
    Applicants: POZEN INC., HORIZON PHARMA USA, INC.
    Inventors: Brian AULT, Clara HWANG, Everardus Orlemans, John R. PLACHETKA, Mark SOSTEK
  • Method for treating a patient at risk for developing an NSAID-associated ulcer
    Patent number: 8945621
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: February 3, 2015
    Assignees: Pozen Inc., Horizon Pharma USA, Inc.
    Inventors: Brian Ault, Clara Hwang, Everardus Orlemans, John R Plachetka, Mark Sostek
  • Method for Treating a Patient at Risk for Developing an NSAID-associated Ulcer
    Publication number: 20100330179
    Abstract: The present disclosure is directed to a method for treating a disease or disorder in a patient at risk of developing an NSAID-associated ulcer by administering to said patient in need thereof a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof to said at risk patient and thereby decreasing the patient's risk of developing an ulcer.
    Type: Application
    Filed: June 24, 2010
    Publication date: December 30, 2010
    Applicants: ASTRAZENECA AB, POZEN INC.
    Inventors: Brian Ault, Clara Hwang, Everardus Orlemans, John R. Plachetka, Mark Sostek
  • Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
    Publication number: 20100062064
    Abstract: The present disclosure is directed to a method for delivering a pharmaceutical composition to a patient in need thereof, comprising: administering to said patient a pharmaceutical composition in unit dose form comprising naproxen, or pharmaceutically acceptable salt thereof, and esomeprazole, or pharmaceutically acceptable salt thereof
    Type: Application
    Filed: September 3, 2009
    Publication date: March 11, 2010
    Applicants: ASTRAZENECA UK LTD., POZEN INC.
    Inventors: Brian Ault, Mark Sostek, Everardus Orlemans, John R. Plachetka